Masatoshi Yuri

401 total citations
13 papers, 269 citations indexed

About

Masatoshi Yuri is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Masatoshi Yuri has authored 13 papers receiving a total of 269 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Immunology. Recurrent topics in Masatoshi Yuri's work include interferon and immune responses (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Mass Spectrometry Techniques and Applications (2 papers). Masatoshi Yuri is often cited by papers focused on interferon and immune responses (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Mass Spectrometry Techniques and Applications (2 papers). Masatoshi Yuri collaborates with scholars based in Japan and United States. Masatoshi Yuri's co-authors include Masashi Hiramoto, Hiroyuki Yokota, Masahiro Takeuchi, Naoto Nakamura, Naoki Kaneko, Isao Kinoyama, Akira Matsuhisa, Hiroshi Koutoku, Takahito Nakahara and Kiyoshi Furuichi and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and British Journal of Cancer.

In The Last Decade

Masatoshi Yuri

13 papers receiving 264 citations

Peers

Countries citing papers authored by Masatoshi Yuri

Since Specialization

Citations

This map shows the geographic impact of Masatoshi Yuri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masatoshi Yuri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masatoshi Yuri more than expected).

Fields of papers citing papers by Masatoshi Yuri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masatoshi Yuri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masatoshi Yuri. The network helps show where Masatoshi Yuri may publish in the future.

Co-authorship network of co-authors of Masatoshi Yuri

This figure shows the co-authorship network connecting the top 25 collaborators of Masatoshi Yuri. A scholar is included among the top collaborators of Masatoshi Yuri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masatoshi Yuri. Masatoshi Yuri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Characterisation of a novel KRAS G12C inhibitor ASP2453 that shows potent anti-tumour activity in KRAS G12C-mutated preclinical models 2021 ·British Journal of Cancer ·Ayako Nakayama, Takeyuki Nagashima, (unknown), (unknown), Kenichi Mori, (unknown), Masatoshi Yuri, Masashi Shimazaki	14
2	Mutant-Selective Irreversible EGFR Inhibitor, Naquotinib, Inhibits Tumor Growth in NSCLC Models with EGFR-Activating Mutations, T790M Mutation, and AXL Overexpression 2019 ·Molecular Cancer Therapeutics ·Hiroaki Tanaka, Hideki Sakagami, Naoki Kaneko, (unknown), Hiroko Yamamoto, (unknown), Masatoshi Yuri, (unknown), Masamichi Mori, Masahiro Takeuchi, Hiroyuki Koshio, Masaaki Hirano, Sadao Kuromitsu	15
3	Inhibition of c-Rel DNA binding is critical for the anti-inflammatory effects of novel PIKfyve inhibitor 2016 ·European Journal of Pharmacology ·(unknown), (unknown), Naoto Nakamura, Masatoshi Yuri, Masashi Hiramoto, Masanori Naitou, Kazuyuki Hattori, Hiroyuki Yokota, Hidekazu Mizuhara, Yasuyuki Higashi	11
4	Abstract 1728: ASP8273, a novel mutant-selective irreversible EGFR inhibitor, inhibits growth of non-small cell lung cancer (NSCLC) cells with EGFR activating and T790M resistance mutations 2014 ·Cancer Research ·Hideki Sakagami, (unknown), Hiroko Yamamoto, Hiroaki Tanaka, (unknown), Masamichi Mori, Hiroyuki Koshio, Masatoshi Yuri, Masaaki Hirano, Sadao Kuromitsu	18
5	Sepantronium Bromide (YM155) induces disruption of the ILF3/p54nrb complex, which is required for survivin expression 2012 ·Biochemical and Biophysical Research Communications ·Tomohiro Yamauchi, Naoto Nakamura, Masashi Hiramoto, Masatoshi Yuri, Hiroyuki Yokota, Masanori Naitou, Masahiro Takeuchi, Kentaro Yamanaka, Aya Kita, Takahito Nakahara, Isao Kinoyama, Akira Matsuhisa, Naoki Kaneko, Hiroshi Koutoku, Masao Sasamata, Masato Kobori, (unknown), Shuichi Tawara, Shigeki Kawabata, Kiyoshi Furuichi	62
6	Interleukin Enhancer-binding Factor 3/NF110 Is a Target of YM155, a Suppressant of Survivin 2012 ·Molecular & Cellular Proteomics ·Naoto Nakamura, Tomohiro Yamauchi, Masashi Hiramoto, Masatoshi Yuri, Masanori Naito, Masahiro Takeuchi, Kentaro Yamanaka, Aya Kita, Takahito Nakahara, Isao Kinoyama, Akira Matsuhisa, Naoki Kaneko, Hiroshi Koutoku, Masao Sasamata, Hiroyuki Yokota, Shigeki Kawabata, Kiyoshi Furuichi	60
7	Identification and Relative Quantitation of an Orphan G-Protein Coupled Receptor SREB2 (GPR85) Protein in Tissue Using a Linear Ion Trap Mass Spectrometer 2011 ·Journal of Proteome Research ·Masatoshi Yuri, Masashi Hiramoto, Masanori Naito, Mitsuyuki Matsumoto, Shun‐ichiro Matsumoto, (unknown), (unknown), Hiroyuki Yokota, Toshio Teramura	2
8	Combination of MS Protein Identification and Bioassay of Chromatographic Fractions to Identify Biologically Active Substances from Complex Protein Sources 2009 ·Molecular & Cellular Proteomics ·Sadao Kuromitsu, Hiroyuki Yokota, Masashi Hiramoto, Masatoshi Yuri, Masanori Naitou, Naoto Nakamura, Shigeki Kawabata, Masato Kobori, Masao Katoh, (unknown), Haruhisa Mita, Tetsuo Yamada	2
9	Absence of Increased α1-Microglobulin in IgA Nephropathy Proteinuria 2007 ·Molecular & Cellular Proteomics ·Hiroyuki Yokota, Masashi Hiramoto, Hirokazu Okada, Yoshihiko Kanno, Masatoshi Yuri, (unknown), Masanori Naitou, Atsushi Ichikawa, Masao Katoh, Hiromichi Suzuki	27
10	Reversal of expression of 15‐lipoxygenase‐1 to cyclooxygenase‐2 is associated with development of colonic cancer 2007 ·Histopathology ·Masatoshi Yuri, Tomonori Sasahira, Kenta Nakai, Shinya Ishimaru, Hitoshi Ohmori, Hiroki Kuniyasu	30
11	Synthesis and inhibitory effects of bivalent sialyl lewis X analogs at preventing cell adhesion 1997 ·Bioorganic & Medicinal Chemistry Letters ·Hiroshi Miyauchi, Masatoshi Yuri, Masashi Tanaka, (unknown), Masaji Hayashi	12
12	Non-stereoselective Formation of 3.ALPHA.,7.ALPHA.,12.ALPHA.,24-Tetrahydroxy-5.BETA.-cholestan- 26-oic Acid during Cholic Acid Biosynthesis. 1994 ·Chemical and Pharmaceutical Bulletin ·Noriko Kobayashi, (unknown), Masuo Morisaki, Masatoshi Yuri, (unknown), Yoshinori Fujimoto	5
13	Identification of 27-Nor-3.ALPHA.,7.ALPHA.,12.ALPHA.-trihydroxycoprostan-24-one Apparently Derived from 3.ALPHA.,7.ALPHA.,12.ALPHA.-Trihydroxy-24-oxocoprostanoic Acid, a Postulated Intermediate of Bile Acid Biosynthesis. 1993 ·Chemical and Pharmaceutical Bulletin ·Masatoshi Yuri, (unknown), Noriyuki Hara, Yoshinori Fujimoto, Noriko Kobayashi, Masuo Morisaki	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact